About US
Contact us
-
Novavax to receive $350M from Canada for canceled COVID vaccine ordersAs Novavax works to endure uncertain demand for its COVID-19 vaccine, the company's close relationship with Canada is taking a new form. The country has canceled some COVID-2023/7/11
-
WuXi Bio telegraphs spinoff of its bioconjugate subsidiary XDCAngling for greater independence, it appearsthe time has come for WuXi’s bioconjugation offspring to leave the nest. WuXi Biologics hasunveileda proposed spinoff and separate listing of WuXi XDC C2023/7/11
-
Cipla pulls 6 batches of asthma med albuterol after inhaler leak complaintCipla, which was recently hit with a 23-page Form 483 filing from the FDA, is adding to the albuterol supply strain with a U.S. recall of six batches of the asthma med. The2023/7/7
-
FDA slams Intas, Ipca over manufacturing shortfalls at 3 Indian plantsAfter a pandemic-fueled lull the past few years, FDA inspections are back in full force. This week,a pair of Indian drugmakers have found themselves in the agency’s crosshairs.2023/7/7
-
Teva weighs sale of $2B API business as CEO Richard Francis embarks on 'Pivot to Growth' strategy: reportsLess than two months into its "Pivot to Growth" strategy under a new CEO, Israeli-American generics giant Teva Pharmaceutical could be weighing a major shake-up of its key drug ingredients business.2023/7/5
-
Go for the Gulf: Sanofi partners with local drugmakers to crank out vaccines at new manufacturing plant in Saudi ArabiaAfter AstraZeneca and National Resilience made recent inroads into the United Arab Emirates, Sanofi has emerged as the next pharmaceutical giant setting its sights on the Middle East.2023/7/5
-
Moderna strikes deal worth up to $1B to develop, produce mRNA drugs in China: reportsDespite political tensions between Washington and Beijing, foreign pharmaceutical investments are progressingin China. Now, as the commerce minister of the world’s second largest economy signals the2023/7/3
-
Samsung Biologics, Pfizer expand biosimilar production partnership with pair of deals worth $897MWith Pfizer set this month to launch its biosimilar version of AbbVie’s mega-blockbuster Humira, the company has expanded its partnership with Samsung Biologics, which will produce biosimilars for th2023/7/3
-
SK bioscience inks deal to support vaccine manufacturing in ThailandSK biosciencesigned a memorandum of understandingwith Thailand’s Government Pharmaceutical Organization to help develop the country’s vaccine manufacturing sector, with the partners aiming to turn th2023/6/27
-
Antibody aficionado Abcam explores strategic alternatives—including a potential saleHalf a decade after Abcam quit its 270 million pound sterling pursuit of Horizon Discovery, the British antibody research expert has potentially found itself on the opposite end of the dealmaking tab2023/6/27